Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Tests a 5-week digital breathing program in children with muscular dystrophy

Tests a digital breathing program in children with Duchenne or Becker muscular dystrophy.

Plain-language title generated from the registry record
Registry title: Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.

Key facts

Where
Málaga, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 5 and 20 years old?

Source: NCT06363526, who can take part

Where in Spain

  • Rocío Martín-ValeroMálaga, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Malaga
Trial code
NCT06363526
Record updated
1 April 2025
Original description
The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.Read full original descriptionShow less

Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

Inclusion: Participants with Duchenne muscular dystrophy and patients with Becker muscular dystrophy will be chosen; Aged between 5 and 20 years; Child who could walk and follow the intervention program, and were diagnosed according to the International Classification of Diseases, 10 Revision. code (G71-01); and who had an NSSA score greater than 20.

Exclusion: Patients who present associated heart disease; Patients who presentor fractures, a heart rate greater than 120 beats per minute, or an oxygen saturation less than 89% will be excluded; Participants who do not have the capacity to have internet at home to perform the intervention, as well as all patients whose caregivers did not agree to sign the informed consent.

ClinicalTrials.gov NCT06363526